Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Aspira Womens Health (AWH) stocks in Canada

Learn how to easily invest in Aspira Womens Health stocks.

Aspira Womens Health is a diagnostics & research business based in the US. Aspira Womens Health stocks (AWH.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $5.78 – a decrease of 7.72% over the previous week. Aspira Womens Health employs 0 staff and has a trailing 12-month revenue of around $6.4 million.

How to buy shares in Aspira Womens Health

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – AWH – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Aspira Womens Health stock price (NASDAQ:AWH)

Use our graph to track the performance of AWH stocks over time.

Aspira Womens Health shares at a glance

Information last updated 2022-01-26.
Latest market close$1.14
52-week range$0.99 - $10.54
50-day moving average $1.81
200-day moving average $3.85
Wall St. target price$4.00
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-0.27

Compare online stock trading platforms

Note: The dollar amounts in the table below are in Canadian dollars.

Name Product Finder Rating Stock Trading Fee Account Fee Available Asset Types Offer
FREE TRADES
Wealthsimple Trade
Finder Rating:
★★★★★
3.9 / 5
$0
$0
Stocks, ETFs
Get 2 free stocks when you deposit and trade $150.
Scotia iTRADE
Finder Rating:
★★★★★
3.8 / 5
$4.99 - $9.99
$0
Bonds, Options, Mutual Funds, ETFs, GICs, International Equities
Interactive Brokers
Finder Rating:
★★★★★
4.1 / 5
Min. $1.00, Max. 0.5%
$0
Stocks, Bonds, Options, ETFs, Currencies, Futures
OFFER
CIBC Investor's Edge
Finder Rating:
★★★★★
4 / 5
$4.95 - $6.95
$0 if conditions met, otherwise $100/year
Stocks, Bonds, Options, Mutual Funds, ETFs
Get up to $2,000 cash back. Conditions apply. Offer ends March 1, 2022.
Questrade
Finder Rating:
★★★★★
4.2 / 5
$4.95 - $9.95
$0
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs, International Equities, Precious Metals
Get $50 in free trades when you fund your account with a minimum of $1,000.
Qtrade Direct Investing
Finder Rating:
★★★★★
4.1 / 5
$6.95 - $8.75
$0 if conditions met, otherwise $25/quarter
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs
Get up to $5,000 cash back. Conditions apply. Offer ends March 1, 2022.
loading

Compare up to 4 providers

Online stock trading

Is it a good time to buy Aspira Womens Health stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Aspira Womens Health price performance over time

Historical closes compared with the close of $1.135 from 2022-01-25

1 week (2022-01-19) -7.72%
1 month (2021-12-23) -39.95%
3 months (2021-10-26) -60.86%
6 months (2021-07-26) -76.05%
1 year (2021-01-26) -84.64%
2 years (2020-01-24) 40.12%
3 years (2019-01-25) 59.77%
5 years (2017-01-26) 1.19

Aspira Womens Health financials

Revenue TTM $6.4 million
Gross profit TTM $1.2 million
Return on assets TTM -53.6%
Return on equity TTM -108.5%
Profit margin 0%
Book value $0.34
Market capitalisation $127.3 million

TTM: trailing 12 months

Aspira Womens Health share dividends

We're not expecting Aspira Womens Health to pay a dividend over the next 12 months.

Have Aspira Womens Health's shares ever split?

Aspira Womens Health's shares were split on a 1:10 basis on 3 March 2008. So if you had owned 10 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Aspira Womens Health shares – just the quantity. However, indirectly, the new 900% higher share price could have impacted the market appetite for Aspira Womens Health shares which in turn could have impacted Aspira Womens Health's share price.

Aspira Womens Health share price volatility

Over the last 12 months, Aspira Womens Health's shares have ranged in value from as little as $0.99 up to $10.54. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Aspira Womens Health's is 2.8632. This would suggest that Aspira Womens Health's shares are significantly more volatile than the average for this exchange and represent a higher risk.

Aspira Womens Health overview

Aspira Women's Health Inc. , together with its subsidiaries, discovers, develops, and commercializes diagnostic and bio-analytical solutions that help physicians to diagnose, treat, and enhance gynecologic health outcomes for women in the United States. It provides OVA1, Overa, and Ova1PLUS to detect the risk of ovarian malignancy. The company also offers ASPiRA GenetiX, a genetic test for the risk of gynecologic cancer. In addition, it owns and operates ASPiRA LABS, a lab that specializes in applying biomarker-based technologies to address critical needs in the management of gynecologic cancers and disease. Further, the company is developing diagnostic algorithms; and a high-risk screening algorithm for patients who are genetically predisposed to ovarian cancer. It has entered into a collaborative research agreement with Baylor Genetics to co-develop a novel ovarian cancer early-detection test; and an agreement with Dana Farber Cancer Institute, Brigham and Women's Hospital, and Medical University Lodz to evaluate the microRNA technology in combination with Aspira technologies for the development of an early detection test for ovarian cancer.

Frequently asked questions


Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.

More on investing

More guides on Finder

Go to site